Frankfurt - Delayed Quote ? EUR Moberg Pharma AB (publ) (MB8.F) Follow Compare 1.0000 +0.0250 (+2.56%) As of 8:17 AM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for MB8.F 1D 5D -2.53% 1M 22.93% 3M -66.08% YTD -27.01% 1Y 41.84% 2Y -23.56% 5Y -94.74% All -95.34% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: MB8.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Cipher Pharmaceuticals Down 16% as Partner Moberg Pharma AB Provides Lower Than Expected Study Results PREMIUM MT Newswires ? last month Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients PR Newswire ? last month Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors - subscription rate in TO 2 of 98% PR Newswire ? 4 months ago Moberg Pharma has secured exercise of warrants and entered into a top guarantee free of charge PR Newswire ? 4 months ago MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication PR Newswire ? 8 months ago View More
